Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Living with dementia

alcohol-related brain damage1 - syndrome of dementia1 - signs of dementia6 - early alzheimer's disease1 - memory robbing disease1 - physical discomfort1 - statins1 - synaptic loss1 - alzheimer’s patients1 - neurofibrillary tangle1 - exposure to ddt1 - prostate cancer1 - alzheimer's treatments3 - emotional lability1 - problems with speech1 - dementia sufferers1 - cognitive deterioration2 - hypertension3 - baroness thatcher1 - oxidative stress1 - neuropsychological evaluations1 - huntington disease2 - judgment1 - treatment of alzheimer's1 - brain disorder1 - apoe gene3 - mediterranean and dash1 - encephalopathy-alcoholic10 - symptomatic benefit1 - terminal cognitive failure1 -